Full Press Release Details
INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
| Unaudited Condensed Consolidated Financial Statements as of June 30, 2024 and for the Six Months Ended June 30, 202 4 and 202 3 | |
| Condensed Consolidated Balance Sheets as of June 30, 202 4 (Unaudited) and December 31, 202 3 | F-2 |
| Condensed Consolidated Statements of L oss for the Six Months Ended June 30, 202 4 and 202 3 (Unaudited) | F-3 |
| Condensed Consolidated Statements of Shareholders' E quity (D eficit ) for the Six Months Ended June 30, 202 4 and 202 3 (Unaudited) | F-4 |
| Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 202 4 and 202 3 (Unaudited) | F-5 |
| Notes to Condensed Consolidated Financial Statements for the Six Months Ended June 30, 202 4 and 202 3 (Unaudited) | F-7 |
MEDIROM HEALTHCARE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF JUNE 30, 2024 (UNAUDITED) AND DECEMBER 31, 2023
(Yen in thousands, except share data)
| June 30, | December 31, | |||||
| 2024 | 2023 | |||||
| (Unaudited) | ||||||
| ASSETS | ||||||
| Current assets: | ||||||
| Cash and cash equivalents | 144,648 | 106,347 | ||||
| Accounts receivable-trade, net of allowances of 15,932 and 15,925, respectively | 76,733 | 621,867 | ||||
| Accounts receivable-other, net of allowances of 457 and 457 respectively | 536,484 | 606,074 | ||||
| Inventories | 160,207 | 139,982 | ||||
| Prepaid expenses and other current assets | 188,733 | 284,434 | ||||
| Total current assets | 1,106,805 | 1,758,704 | ||||
| Property and equipment, net | 407,412 | 451,498 | ||||
| Goodwill | 472,209 | 484,564 | ||||
| Other intangible assets, net | 781,317 | 920,700 | ||||
| Investments | 81,542 | 81,542 | ||||
| Long-term accounts receivable-other, net of allowances of 111,093 and 116,547, respectively | 95,560 | 95,797 | ||||
| Right-of-use asset - operating lease, net | 1,958,629 | 2,089,402 | ||||
| Lease and guarantee deposits | 808,733 | 848,691 | ||||
| Deferred tax assets, net | 101,636 | 101,636 | ||||
| Other assets | 13,198 | 16,655 | ||||
| Total assets | 5,827,041 | 6,849,189 | ||||
| LIABILITIES AND SHAREHOLDERS' DEFICIT | ||||||
| Current liabilities: | ||||||
| Accounts payable | 124,436 | 137,697 | ||||
| Accrued expenses | 1,036,247 | 1,261,909 | ||||
| Short-term borrowings | 500,000 | 400,000 | ||||
| Current portion of long-term borrowings | 92,716 | 100,415 | ||||
| Accrued income taxes | 4,816 | 14,888 | ||||
| Current portion of contract liability | 78,320 | 109,307 | ||||
| Advances received | 228,112 | 402,742 | ||||
| Current portion of lease liability | 741,511 | 763,422 | ||||
| Other current liabilities | 494,609 | 370,213 | ||||
| Total current liabilities | 3,300,767 | 3,560,593 | ||||
| Long-term borrowings - net of current portion | 1,011,481 | 1,050,802 | ||||
| Deposit received | 250,235 | 261,922 | ||||
| Contract liability - net of current portion | 45,615 | 71,134 | ||||
| Lease liability - net of current portion | 1,222,931 | 1,334,630 | ||||
| Asset retirement obligation | 347,633 | 344,346 | ||||
| Other liabilities | 12,692 | 9,801 | ||||
| Total liabilities | 6,191,354 | 6,633,228 | ||||
| COMMITMENTS AND CONTINGENCIES (NOTE 12) | ||||||
| SHAREHOLDERS' (DEFICIT) EQUITY: | ||||||
| Common stock, no par value; 19,899,999 shares authorized; 5,030,850 shares issued and 4,938,350 shares outstanding at June 30, 2024; 4,975,000 shares issued and 4,882,500 shares outstanding at December 31, 2023 | 19,900 | 19,900 | ||||
| Class A common stock, no par value; 1 share authorized; 1 share issued and 1 share outstanding at June 30, 2024 and December 31, 2023 | 100 | 100 | ||||
| Treasury stock, at cost- 92,500 common shares at June 30, 2024 and December 31, 2023 | (3,000) | (3,000) | ||||
| Additional paid-in capital | 121,703 | 113,602 | ||||
| (Accumulated deficit) Retained earnings | (501,904) | 80,277 | ||||
| Total 'equity (deficit) attributable to shareholders of the Company | (363,201) | 210,879 | ||||
| Noncontrolling interests | (1,112) | 5,082 | ||||
| Total shareholders' (deficit) equity | (364,313) | 215,961 | ||||
| Total liabilities and shareholders' (deficit) equity | 5,827,041 | 6,849,189 |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MEDIROM HEALTHCARE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE SIX MONTHS ENDED JUNE 30, 2024
AND 2023 (UNAUDITED)
(Yen in thousands, except share and per share data)
| Six months ended June 30, | ||||||
| 2024 | 2023 | |||||
| Revenues: | ||||||
| Revenue from directly-operated salons | 3,015,663 | 2,598,467 | ||||
| Franchise revenue | 415,923 | 489,593 | ||||
| Other revenues | 43,695 | 62,730 | ||||
| Total revenues | 3,475,281 | 3,150,790 | ||||
| Cost of revenues and operating expenses: | ||||||
| Cost of revenue from directly-operated salons | 2,653,425 | 2,215,200 | ||||
| Cost of franchise revenue | 156,014 | 269,229 | ||||
| Cost of other revenues | 89,278 | 56,185 | ||||
| Selling, general and administrative expenses | 1,213,238 | 989,222 | ||||
| Total cost of revenues and operating expenses | 4,111,955 | 3,529,836 | ||||
| Operating loss | (636,674) | (379,046) | ||||
| Other (expense) income: | ||||||
| Dividend income | 2 | 2 | ||||
| Interest income | 2 | 1 | ||||
| Interest expense | (20,631) | (16,859) | ||||
| Gain from sales of salons | 31,793 | 68,783 | ||||
| Subsidies | 13,855 | 10,877 | ||||
| Other, net | 26,883 | (35,089) | ||||
| Total other income | 51,904 | 27,715 | ||||
| Loss before income tax expense | (584,770) | (351,331) | ||||
| Income tax expense | 3,605 | 3,735 | ||||
| Net loss | (588,375) | (355,066) | ||||
| Less: Net loss attributable to noncontrolling interests | (6,194) | |||||
| Net loss attributable to shareholders of the Company | (582,181) | (355,066) | ||||
| Net loss per share attributable to shareholders of the Company | ||||||
| Basic | (118.56) | (72.72) | ||||
| Diluted | (118.56) | (72.72) | ||||
| Weighted average shares outstanding | ||||||
| Basic | 4,910,426 | 4,882,500 | ||||
| Diluted | 4,910,426 | 4,882,500 |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MEDIROM HEALTHCARE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT)
FOR THE SIX MONTHS ENDED JUNE 30, 2024
AND 2023 (UNAUDITED)
(Yen in thousands, except share data)
| Class A common | |||||||||||||||||||||||||||
| Common stock | stock | Treasury stock | |||||||||||||||||||||||||
| Retained | |||||||||||||||||||||||||||
| Additional | earnings | Non | Total | ||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | paid-in | (accumulated | controlling | |||||||||||||||||||
| capital | deficit) | interest | |||||||||||||||||||||||||
| Balance, December 31, 2022 | 4,975,000 | 1,223,134 | 1 | 100 | 92,500 | (3,000) | 1,265,456 | (2,545,068) | (59,378) | ||||||||||||||||||
| Reduction in common stock and additional paid-in capital (1) | (1,203,234) | (1,265,456) | 2,468,690 | ||||||||||||||||||||||||
| Net loss | (355,066) | (355,066) | |||||||||||||||||||||||||
| Balance, June 30, 2023 | 4,975,000 | 19,900 | 1 | 100 | 92,500 | (3,000) | (431,444) | (414,444) | |||||||||||||||||||
| Balance, December 31, 2023 | 4,975,000 | 19,900 | 1 | 100 | 92,500 | (3,000) | 113,602 | 80,277 | 5,082 | 215,961 | |||||||||||||||||
| Issuance of common stock from stock option exercises | 55,850 | 8,101 | 8,101 | ||||||||||||||||||||||||
| Net loss | (582,181) | (6,194) | (588,375) | ||||||||||||||||||||||||
| Balance, June 30, 2024 | 5,030,850 | 19,900 | 1 | 100 | 92,500 | (3,000) | 121,703 | (501,904) | (1,112) | (364,313) |
(1)On March 31, 2023, upon the resolution of the stockholders, a reduction in the registered capital and additional reserved capital amount for common stock was approved in accordance with the Companies Act. As a result, the amounts were reclassified from registered capital and additional reserved capital for common stock to accumulated deficit.
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MEDIROM HEALTHCARE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2024
AND 2023 (UNAUDITED)
| Six months ended June 30, | ||||||
| 2024 | 2023 | |||||
| Cash flows from operating activities: | ||||||
| Net loss | (588,375) | (355,066) | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
| Depreciation and amortization | 196,102 | 100,849 | ||||
| Gains from sale of directly-owned salons | (380,901) | (350,813) | ||||
| Bad debt | (5,445) | 6,735 | ||||
| Losses on disposal of property and equipment, net, other intangible assets, net and goodwill | 4,667 | 2,175 | ||||
| Other non-cash losses - net | (2,078) | 47,909 | ||||
| Changes in operating assets and liabilities: | ||||||
| Accounts receivable-trade | 295,113 | (87,134) | ||||
| Accounts receivable-other | 69,590 | 282,116 | ||||
| Inventories | (20,225) | (79,714) | ||||
| Prepaid expenses and other current assets | 24,516 | 26,360 | ||||
| Lease and guarantee deposits | 39,044 | 42,211 | ||||
| Accounts payable | (13,261) | 2,326 | ||||
| Accrued expenses | (279,847) | (382,096) | ||||
| Accrued income taxes | (10,072) | (35,347) | ||||
| Contract liability | (56,506) | (2,700) | ||||
| Advances received | (174,630) | (148,792) | ||||
| Other current liabilities | 124,397 | 337,493 | ||||
| Deposit received | (11,687) | (16,073) | ||||
| Other assets and other liabilities - net | 3,878 | (476) | ||||
| Net cash used in operating activities | (785,720) | (610,037) | ||||
| Cash flows from investing activities: | ||||||
| Purchases of time deposits | (5,656) | |||||
| Proceeds from maturities of time deposits | 26,004 | |||||
| Acquisition of property and equipment | (18,695) | (56,241) | ||||
| Cost additions to other intangible assets | (158,032) | (83,618) | ||||
| Proceeds from sale of salons | 917,941 | 315,400 | ||||
| Payment received on short-term loans receivable | 112 | |||||
| Payment received on long-term accounts receivable-other | 1,670 | |||||
| Net cash provided by investing activities | 763,232 | 175,653 |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MEDIROM HEALTHCARE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2024
AND 2023 (UNAUDITED)-(CONTINUED)
| Six months ended June 30, | ||||||
| 2024 | 2023 | |||||
| Cash flows from financing activities: | ||||||
| Proceeds from issuance of common stock | 8,101 | |||||
| Proceeds from short-term borrowings | 300,000 | |||||
| Repayment of short-term borrowings | (200,000) | |||||
| Repayment of long-term borrowings | (47,312) | (53,342) | ||||
| Net cash provided by (used in) financing activities | 60,789 | (53,342) | ||||
| Net increase (decrease) in cash and cash equivalents | 38,301 | (487,726) | ||||
| Cash and cash equivalents at beginning of period | 106,347 | 605,454 | ||||
| Cash and cash equivalents at end of period | 144,648 | 117,728 | ||||
| Supplemental disclosure of cash flow information: | ||||||
| Cash paid during the period for: | ||||||
| Interest | 19,737 | 13,986 | ||||
| Income taxes | 13,009 | 36,419 | ||||
| Non-cash investing and financing activities: | ||||||
| Right-of-use assets obtained in exchange for lease liabilities | 271,225 | 459,137 | ||||
| Purchases of property and equipment included in accrued expenses | 14,589 | 19,139 | ||||
| Purchases of intangible assets included in accrued expenses | 25,100 | 13,077 | ||||
| Sales of salons included in accounts receivable | 102,000 | |||||
| Reduction in common stock and additional paid-in capital | 2,468,690 |
Refer to Note 4, "Leases" for supplemental cash flow information related to leases.
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MEDIROM HEALTHCARE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND 2023
1. Basis of Presentation and Summary of Significant Accounting Policies
Unaudited Condensed Consolidated Financial Statements
The condensed consolidated financial statements included herein are unaudited and have been prepared solely by the Company's management pursuant to the rules and regulations of the U.S. Securities and Exchange Commission for interim financial reporting.
Description of Business
MEDIROM Healthcare Technologies Inc. ("Parent") and its eight subsidiaries (collectively, the "Company") are one of the leading holistic health services providers in Japan. The Company is a franchisor and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers, and government entities to affect positive health outcomes. The Company primarily engages in three lines of business: Relaxation Salon Segment (retail), Luxury Beauty (retail) and Digital Preventative Healthcare Segment (healthtech). Refer to description below and Note 6 for segment information.
Relaxation Salon Segment (See Note 6 for segment information)
The Relaxation Salon Segment is the core of the Company's business, whereby the Company owns, develops, operates, or franchises and supports relaxation salons. The salon locations cover major cities throughout Japan, with strong market presence in the Tokyo metropolitan area. The Segment includes several Relaxation Salon brands including Re.Ra.Ku , and as of June 30, 2024 and December 31, 2023, it has a total of 308 and 314 salons, respectively. The following table presents total number of salons by operation type:
| Number of | ||||
| Relaxation Salons | ||||
| As of June 30, | As of December 31, | |||
| 2024 | 2023 | |||
| Directly-operated | 215 | 217 | ||
| Franchised | 93 | 97 | ||
| Total | 308 | 314 |
The number of Directly-operated salons include 60 and 41 investor-owned salons as of June 30, 2024 and December 31, 2023, respectively.
Digital Preventative Healthcare Segment (See Note 6 for segment information)
The Digital Preventative Healthcare Segment mainly consists of the following operations: government-sponsored Specific Health Guidance program, utilizing our internally-developed on-demand health monitoring smartphone application, or Lav ; MOTHER Bracelet for fitness applications.
Luxury Beauty Segment (See Note 6 for segment information)
The Luxury Beauty Segment is a business line acquired in October 2021 and operates high brand beauty salons in the central areas of Tokyo.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements are presented in Japanese yen, the currency of the country in which the Company is incorporated and principally operates. The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") for interim financial statements. Accordingly, they do not include all disclosures required by accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information.
The results of operations for interim period are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2024 or for any other future annual or interim period. The accompanying unaudited condensed consolidated financial information should be read in conjunction with the Company's annual financial statements and notes included in the Company's Annual Report on Form 20-F for the year ended December 31, 2023, which was filed with the SEC on June 18, 2024.
Recent Developments and Liquidity
In the six months ended June 30, 2024, the Company experienced negative cash flows from operations. Since 2020, the Company has had losses from operations. As of June 30, 2024, the Company had an accumulated deficit. However, the Company's adjusted EBITDA, which includes proceeds from sales of salons classified as an investing activity in the cash flow statement, was ( 404,112 thousand) and ( 207,239 thousand) during the six months ended June 30, 2024 and 2023, respectively.
In evaluating our ability to continue as a going concern, management considered the conditions and events which could raise substantial doubt about our ability to continue as a going concern for one year following the date the consolidated financial statements for the six months ended June 30, 2024 are issued. Management considered our current financial condition and liquidity sources, including current funds available, forecasted future cash flows, and our conditional and unconditional obligations due. As such, we expect that our cash and cash equivalents as of June 30, 2024 of 144,648 thousand will not be sufficient to fund our operating expenses, capital expenditure requirements, and debt service obligations for the 12 months after the issuance date of these consolidated financial statements and that we would require additional capital in the future. These conditions, among others, raise substantial doubt about the ability of the Company to continue as a going concern. Management plans to alleviate the conditions that raise substantial doubt by raising capital through the issuance of common stock including a follow-on offering for which the Company filed a F-1 registration statement on August 23, 2024 (to be amended), private placements, borrowings from banks, and the continued sales of directly-owned salons to investors. However, the Company's ability to issue equity securities or obtain debt financing on acceptable terms, or at all, will depend on, among other things, its financial performance, general economic factors, including inflation and then-current interest rates, the condition of the credit and capital markets and other events, some of which may be beyond the Company's control.
The Company reclassified certain amount of revenue ( 92,000 thousand) and cost of sales ( 23,217 thousand) into gain from sale of salons ( 68,783 thousand) in the condensed consolidated statements of operations for the six-month period ended June 30, 2023, to conform with the new accounting policy described in the notes to the annual financial statements. In addition, a reduction in the registered capital and additional reserved capital amount for common stock was approved by the Company's shareholders in accordance with the Japan's Companies Act on March 31, 2023. The amount available for the reduction in the registered capital and additional reserved capital under Japan's Companies Act is based on the amount recorded in the Company's general books of account, maintained in accordance with accounting principles generally accepted in Japan ("Japanese GAAP"). The additional paid in capital available for the reduction was 1,307 million under the Japanese GAAP on March 31, 2023. However, under U.S. GAAP, the amount available for the reduction was 1,265 million as of March 31, 2023. Therefore, the Company reclassified 1,265 million of additional paid-in capital to retained earnings to prevent a negative balance in additional paid-in capital on March 31, 2023 under U.S. GAAP.
The condensed consolidated financial statements for the six months ended June 30, 2024 include the accounts of Parent and the following subsidiaries: JOYHANDS WELLNESS Inc., Wing Inc., MEDIROM Shared Services Inc., Inc., SAWAN Co., Ltd., ZACC Kabushiki Kaisha ("ZACC"), Medirom Human Resources Inc., MEDIROM MOTHER Labs Inc., and MEDIROM Rehab Solutions Inc. All intercompany transactions have been eliminated in consolidation.
Significant Accounting Policies
The Company's significant accounting policies are described in Note 1 - Basis of Presentation and Summary of Significant Accounting Policies, to the financial statements for the year ended December 31, 2023 included in the Company's Annual Report on Form 20-F for the year ended December 31, 2023, which was filed with the SEC on June 18, 2024. There have been no material changes to the significant accounting policies during the six months ended June 30, 2024.
Recently Issued Accounting Pronouncements Not Yet Adopted
Disclosure Improvements
In October 2023, the FASB issued ASU No. 2023-06, Disclosure Improvements-Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative. This new standard modified the disclosure and presentation requirements of a variety of codification topics by aligning them with the SEC's regulations. ASU 2023-06 will become effective for each amendment on the effective date of the SEC's corresponding disclosure rule changes. The Company does not believe this will have a material impact on its consolidated financial statements.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures. The new standard requires enhanced disclosures about segment information and significant segment expenses. It does not change how a public entity identifies its operating segments. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The new standard should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact on its consolidated financial statements.
In December 2023, the FASB issued 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures. The new standard requires public business entities to disclose information about income taxes paid, specific categories in the rate reconciliation, and additional information for reconciling items that meet a quantitative threshold. The guidance should be applied on a prospective basis. For public business entities, ASU 2023-08 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. For all other entities, the standard is effective for annual periods beginning after December 15, 2025. The Company is currently evaluating the impact on its consolidated financial statements.
2. Goodwill and Other Intangible Assets, Net
The components of intangible assets as of June 30, 2024 and December 31, 2023 are as follows:
| Thousands of Yen | ||||||
| As of | As of | |||||
| June 30, 2024 | December 31, 2023 | |||||
| Intangible assets subject to amortization: | ||||||
| Software for internal use | 224,659 | 220,343 | ||||
| Customer relationship | 180,000 | 180,000 | ||||
| Store operating rights | 559,669 | 637,138 | ||||
| Trademark | 160,000 | 160,000 | ||||
| Other | 750 | 750 | ||||
| Total | 1,125,078 | 1,198,231 | ||||
| Accumulated amortization | (344,130) | (277,900) | ||||
| Net carrying amount | 780,948 | 920,331 | ||||
| Intangible assets not subject to amortization: | ||||||
| Goodwill | 472,209 | 484,564 | ||||
| Telephone rights | 369 | 369 | ||||
| Total | 472,578 | 484,933 | ||||
| Total intangible assets | 1,253,526 | 1,405,264 |
The aggregate amortization expense was 147,205 thousand and 50,305 thousand for the six months ended June 30, 2024 and 2023, respectively.
The following table shows changes in carrying amount of goodwill for the six months ended June 30, 2024 and for the year ended December 31, 2023:
| Thousands of Yen | |||
| Balance at December 31, 2022 | 539,490 | ||
| Sale of directly-owned salons, and closure of directly-owned salons | (54,926) | ||
| Balance at December 31, 2023 | 484,564 | ||
| Sale of directly-owned salons, and closure of directly-owned salons | (12,355) | ||
| Balance at June 30, 2024 | 472,209 |
The Company concluded that there were no triggering events requiring an impairment assessment during the six months ended June 30, 2024. The Company continues to evaluate the impact of macroeconomic conditions.
The Company has borrowings with financial institutions. Some borrowings are secured. As of June 30, 2024 and December 31, 2023, time deposits with an aggregating book value of 6,156 thousand and 26,002, respectively, are pledged as collateral which is included in other current assets in the condensed consolidated balance sheets. Some borrowings are guaranteed by Credit Guarantee Association, a Japanese governmental affiliate agency which supplements private companies with credit. As of June 30, 2024 and December 31, 2023, the borrowings accrue interest using fixed interest rates of 0.21% - 3.30% per annum. Debt issuance costs related to these borrowings are immaterial.
On March 29, 2024, the Company reached an agreement with its lender and refinanced its 200 million yen short-term loan with a new 300 million yen short-term loan maturing on September 30, 2024 at an interest rate of 1-month TIBOR plus 1.2%.
The Company issued corporate convertible bonds in the aggregate amount of 500,000 thousand to Kufu Company Inc., a Japanese company, in December 2022, the terms of which the Company amended on November 1, 2024. The maturity date of the corporate convertible bonds changed from December 28, 2027 to December 31, 2025. The bonds are unsecured, accrue interest at a rate of 5.0% per annum, payable on June 30, 2023 and semi-annually thereafter, and will mature on December 31, 2025, unless earlier converted. At any time between the six-month anniversary date of December 28, 2022 and before the close of business on December 31, 2025, Kufu Company Inc., as the bond holder, may convert the bonds at its option, in whole or in part, into common shares. The Company granted a total of 40 share options, and one share option is attached to each bond equivalent to 12,500,000. The price per share used to calculate the number of the Company's common shares to be delivered upon the exercise of the share options shall be 755.
The carrying value of long-term borrowings as of June 30, 2024 and December 31, 2023 are as follow:
| Thousands of Yen | ||||||
| As of | As of | |||||
| June 30, 2024 | December 31, 2023 | |||||
| Short-term borrowings | 500,000 | 400,000 | ||||
| Borrowings (Due through 2035 with weighted average interest rates of 0.26% as of June 30, 2024, due through 2035 with weighted average interest rates of 0.29% as of December 31, 2023) | 604,197 | 651,217 | ||||
| Corporate convertible bond | 500,000 | 500,000 | ||||
| Current portion of borrowings | (592,716) | (500,415) | ||||
| Borrowings, net of current portion | 1,011,481 | 1,050,802 |
The carrying value of the Company's borrowings approximate fair value at each balance sheet date because the stated rate of interest of the debt approximates the market interest rate at which the Company can borrow similar debt. As of June 30, 2024 and December 31, 2023, the Company did not have any borrowings measured at fair value.
The following is a summary of maturities of long-term borrowings subsequent to June 30, 2024:
| Thousands of Yen | |||
| Year ending December 31: | |||
| 2024 (remainder) | 53,395 | ||
| 2025 | 86,603 | ||
| 2026 | 94,587 | ||
| 2027 | 594,627 | ||
| 2028 | 94,664 | ||
| 2029 and thereafter | 180,321 | ||
| Total | 1,104,197 |
The Company has short-term and long-term borrowings. These borrowings are primarily made under general agreements, which are to provide security and guarantees for present and future indebtedness or to secure a guarantor upon request of the bank, and that the banks shall have the right to offset cash deposits against any debts and obligations that have become due or, in the case of default, against all obligations to the banks. Kouji Eguchi, the representative director and the shareholder of Parent (holds 38.61% of common stock and all Class A common stock as of June 30, 2024) is a guarantor for five bank loans on behalf of the Company. As of June 30, 2024, the outstanding amount of loans guaranteed by Mr. Eguchi was 208,916 thousand. Kazuyoshi Takahashi, the representative director of ZACC, is the guarantor for three bank loans on behalf of ZACC, which were borrowed by ZACC from two banks prior to the acquisition of ZACC. As of June 30, 2024, Mr. Takahashi's guarantee has not been released and the outstanding amount of loans guaranteed by Mr. Takahashi was 47,831 thousand. None of the borrowing agreements contain any financial covenants.
In addition, the Company entered into a 200 million yen credit facility agreement with a bank on August 7, 2023. As of December 31, 2023, the Company had used 200 million yen of the credit facility. On May 31, 2024, the Company renewed the 200 million yen credit facility agreement, which had reached its maturity date. The credit facility agreement was extended for an additional year on the same terms, with a fixed interest rate of 1.475% and a new maturity date of May 30, 2025.
The Company mainly leases commercial space for its relaxation salon from external third parties, which are either operated by the Company or a franchisee and also enters into contracts with franchisees subleasing partial spaces of leased properties under the terms and conditions that are substantially the same as the head lease contracts. As of June 30, 2024 and 2023, the Company had 238 and 237 leased salons, respectively, of which 86 and 96 salons, respectively were subleased.
There are no lease transactions classified as finance leases for the six months ended June 30, 2024 and 2023.
The table below summarizes the components of operating lease costs related to operating leases:
| Thousands of Yen | ||||||
| Six Months Ended June 30, | ||||||
| 2024 | 2023 | |||||
| Fixed lease cost (1) | 455,243 | 458,069 | ||||
| Variable lease cost (1) | 19,927 | 19,676 | ||||
| Short-term cost | 11,598 | 23,550 | ||||
| Total | 486,768 | 501,295 |
There are no sale-and leaseback transactions conducted in the six months ended June 30, 2024 and 2023.
Supplementary information on cash flow and other information for leasing activities for the six months ended June 30, 2024 and 2023 are as follows:
| Thousands of Yen | |||||||
| Six Months Ended June 30, | |||||||
| 2024 | 2023 | ||||||
| Cash paid for amounts included in the measurement of lease liabilities: | |||||||
| Operating cash flows | 486,768 | 501,295 | |||||
| Right-of-use assets obtained in exchange for lease liabilities | 271,225 | 459,137 | |||||
| Weighted average remaining lease term (in years) | 3.5 | 3.8 | |||||
| Weighted average discount rate | 2.02 | % | 2.03 | % |
Maturity analysis of future minimum lease payments under non-cancellable leases subsequent to June 30, 2024 are as follows:
| Thousands of Yen | |||
| Year ending December 31: | |||
| 2024 (remainder) | 399,345 | ||
| 2025 | 657,622 | ||
| 2026 | 460,759 | ||
| 2027 | 268,606 | ||
| 2028 | 150,570 | ||
| 2029 and thereafter | 97,381 | ||
| Total | 2,034,283 | ||
| Less: Interest component | 69,841 | ||
| Present value of minimum lease payments | 1,964,442 |
The amount of 741,511 thousand and 1,222,931 thousand of the discounted present value of minimum lease payment are included in current portion of lease liability and lease liability - net of current portion, respectively, in the condensed consolidated balance sheets.
The Company leases space from commercial facility landlords which in turn it subleases to certain franchisees of its relaxation salons. Sublease revenues are as follows for the six months ended June 30, 2024 and 2023, and included in franchise revenues:
| Thousands of Yen | ||||||
| Six Months Ended June 30, | ||||||
| 2024 | 2023 | |||||
| Fixed sublease income | 152,367 | 178,733 | ||||
| Variable sublease income | 7,037 | 9,224 | ||||
| Total | 159,404 | 187,957 |
Expected future minimum lease collections to be received under non-cancellable subleases subsequent to June 30, 2024 are as follows:
| Thousands of Yen | |||
| Year ending December 31: | |||
| 2024 (remainder) | 124,337 | ||
| 2025 | 206,660 | ||
| 2026 | 121,732 | ||
| 2027 | 49,417 | ||
| 2028 | 25,043 | ||
| 2029 and thereafter | 21,340 | ||
| Total | 548,529 |
There are no lease transactions classified as sale-type leases and direct financing leases for the six months ended June 30, 2024 and 2023.
5. Stock-based Compensation